Nasus Pharma Ltd Conversion of Stock, Shares Converted
Nasus Pharma Ltd (NSRX) reported Conversion of Stock, Shares Converted of 168.11 thousand shares for the 1-month period ending 2023-07-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-03-25
- 2023-07-31: Conversion of Stock, Shares Converted 1 month 168.11K shares.
- 2023-06-30: Conversion of Stock, Shares Converted 1 month 168.11K shares.
| Period end | Conversion of Stock, Shares Converted 1 month |
|---|---|
| 2023-07-31 | 168.11K shares 20-F · filed 2026-03-25 |
| 2023-06-30 | 168.11K shares 20-F · filed 2026-03-25 |